2012•European Journal of Clinical PharmacologyRequires access

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation

Paulo Caleb Júnior Lima Santos, Carla Luana Dinardo, Isolmar Tadeu Schettert, Renata Alonso Gadi Soares, Liz Andrea Kawabata-Yoshihara, Isabela M. Benseñor, José Eduardo Krieger, Paulo A. Lotufo, Alexandre C. Pereira

Open publisher page 36 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: VKORC1, Warfarin, CYP2C9, Medicine, Pharmacogenetics, Term (time), Pharmacology, Vitamin K epoxide reductase